RANIBIZUMAB-EQRN

162 reported adverse events

Drug classes: Vascular Endothelial Growth Factor Inhibitor [EPC]

RANIBIZUMAB-EQRN is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 PRODUCT CONTAMINATION 9 0.0025
1 VITRITIS 3 0.0016
2 CORNEAL DEPOSITS 1 0.0013
3 SUSPECTED PRODUCT CONTAMINATION 1 0.0010
4 DRY AGE-RELATED MACULAR DEGENERATION 1 0.0009
5 ENDOPHTHALMITIS 5 0.0008
6 UNDERDOSE 54 0.0007
7 PRODUCT ADMINISTRATION ERROR 13 0.0006
8 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO DEVICE USE ERROR 1 0.0004
9 VITREOUS HAEMORRHAGE 1 0.0004
See all enriched reactions for RANIBIZUMAB-EQRN